| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.9 |